0001209191-20-007329.txt : 20200206 0001209191-20-007329.hdr.sgml : 20200206 20200206200441 ACCESSION NUMBER: 0001209191-20-007329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200204 FILED AS OF DATE: 20200206 DATE AS OF CHANGE: 20200206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fernando Anthony C. J. CENTRAL INDEX KEY: 0001664960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 20584283 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-04 0 0000876378 TRANSENTERIX, INC. TRXC 0001664960 Fernando Anthony C. J. C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 1 1 0 0 President and CEO Common Stock 2020-02-04 4 M 0 33795 0.00 A 54449 D Common Stock 2020-02-04 4 F 0 16897 1.28 D 37552 D Restricted Stock Units 0.00 2020-02-04 4 M 0 8975 0.00 D Common Stock 8975 17949 D Restricted Stock Units 0.00 2020-02-04 4 M 0 4564 0.00 D Common Stock 4564 4565 D Restricted Stock Units 0.00 2020-02-04 4 M 0 2308 0.00 D Common Stock 2308 0 D Restricted Stock Units 0.00 2020-02-04 4 M 0 2564 0.00 D Common Stock 2564 5129 D Restricted Stock Units 0.00 2020-02-04 4 M 0 15384 0.00 D Common Stock 15384 15385 D Effective December 11, 2019, the Registrant effected a reverse stock split of its common stock at a ratio of one-for-thirteen shares. The amounts set forth in this Form 4 have been adjusted to reflect the reverse stock split. This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. Lapse of forfeiture restrictions on one-third of a restricted stock unit award granted on February 6, 2019. Forfeiture restrictions will lapse on the remaining RSUs in two installments of 8,974 and 8,975 on each of February 4, 2021 and 2022, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Lapse of forfeiture restrictions on one-third of a RSU award granted on February 7, 2018. Forfeiture restrictions will lapse on the remaining 4,565 RSUs on February 4, 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Lapse of forfeiture restrictions on the final 2,308 RSUs from this grant made on February 2, 2017. Lapse of forfeiture restrictions on one-third of a RSU award granted on November 2, 2018. Forfeiture restrictions will lapse on the remaining RSUs in two installments of 2,564 and 2,565 on each of July 3, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Lapse of forfeiture restrictions on one-third of a RSU award granted on July 3, 2017. Forfeiture restrictions will lapse on the remaining 15,385 RSUs on July 3, 2020, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. /s/Joshua Weingard, as Attorney-in-Fact for Anthony Fernando 2020-02-06